1. Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
   Kristina Breitenecker et al, 2023, Frontiers in Oncology CrossRef
2. AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization
   Tugce Batur et al, 2021, International Journal of Molecular Sciences CrossRef